166 related articles for article (PubMed ID: 12411489)
1. An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein.
Pradet-Balade B; Medema JP; López-Fraga M; Lozano JC; Kolfschoten GM; Picard A; Martínez-A C; Garcia-Sanz JA; Hahne M
EMBO J; 2002 Nov; 21(21):5711-20. PubMed ID: 12411489
[TBL] [Abstract][Full Text] [Related]
2. TWE-PRIL; a fusion protein of TWEAK and APRIL.
Kolfschoten GM; Pradet-Balade B; Hahne M; Medema JP
Biochem Pharmacol; 2003 Oct; 66(8):1427-32. PubMed ID: 14555217
[TBL] [Abstract][Full Text] [Related]
3. TWE-PRIL reverse signalling suppresses sympathetic axon growth and tissue innervation.
Howard L; Wosnitzka E; Okakpu D; White MA; Wyatt S; Davies AM
Development; 2018 Nov; 145(22):. PubMed ID: 30337376
[TBL] [Abstract][Full Text] [Related]
4. BAFF, APRIL, TWE-PRIL: who's who?
Daridon C; Youinou P; Pers JO
Autoimmun Rev; 2008 Feb; 7(4):267-71. PubMed ID: 18295728
[TBL] [Abstract][Full Text] [Related]
5. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis.
Chicheportiche Y; Bourdon PR; Xu H; Hsu YM; Scott H; Hession C; Garcia I; Browning JL
J Biol Chem; 1997 Dec; 272(51):32401-10. PubMed ID: 9405449
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Lamprey BAFF-like Gene: Evolutionary Implications.
Das S; Sutoh Y; Hirano M; Han Q; Li J; Cooper MD; Herrin BR
J Immunol; 2016 Oct; 197(7):2695-703. PubMed ID: 27543613
[TBL] [Abstract][Full Text] [Related]
7. Involvement of TWEAK in interferon gamma-stimulated monocyte cytotoxicity.
Nakayama M; Kayagaki N; Yamaguchi N; Okumura K; Yagita H
J Exp Med; 2000 Nov; 192(9):1373-80. PubMed ID: 11067885
[TBL] [Abstract][Full Text] [Related]
8. TWEAK can induce cell death via endogenous TNF and TNF receptor 1.
Schneider P; Schwenzer R; Haas E; Mühlenbeck F; Schubert G; Scheurich P; Tschopp J; Wajant H
Eur J Immunol; 1999 Jun; 29(6):1785-92. PubMed ID: 10382740
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death.
Nakayama M; Ishidoh K; Kojima Y; Harada N; Kominami E; Okumura K; Yagita H
J Immunol; 2003 Jan; 170(1):341-8. PubMed ID: 12496418
[TBL] [Abstract][Full Text] [Related]
10. Soluble tumor necrosis factor-like weak inducer of apoptosis overexpression in HEK293 cells promotes tumor growth and angiogenesis in athymic nude mice.
Ho DH; Vu H; Brown SA; Donohue PJ; Hanscom HN; Winkles JA
Cancer Res; 2004 Dec; 64(24):8968-72. PubMed ID: 15604260
[TBL] [Abstract][Full Text] [Related]
11. Multiple pathways of TWEAK-induced cell death.
Nakayama M; Ishidoh K; Kayagaki N; Kojima Y; Yamaguchi N; Nakano H; Kominami E; Okumura K; Yagita H
J Immunol; 2002 Jan; 168(2):734-43. PubMed ID: 11777967
[TBL] [Abstract][Full Text] [Related]
12. A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications.
Bover LC; Cardó-Vila M; Kuniyasu A; Sun J; Rangel R; Takeya M; Aggarwal BB; Arap W; Pasqualini R
J Immunol; 2007 Jun; 178(12):8183-94. PubMed ID: 17548657
[TBL] [Abstract][Full Text] [Related]
13. TRAIL (Apo2 ligand) and TWEAK (Apo3 ligand) mediate CD4+ T cell killing of antigen-presenting macrophages.
Kaplan MJ; Ray D; Mo RR; Yung RL; Richardson BC
J Immunol; 2000 Mar; 164(6):2897-904. PubMed ID: 10706675
[TBL] [Abstract][Full Text] [Related]
14. A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis.
Wiley SR; Cassiano L; Lofton T; Davis-Smith T; Winkles JA; Lindner V; Liu H; Daniel TO; Smith CA; Fanslow WC
Immunity; 2001 Nov; 15(5):837-46. PubMed ID: 11728344
[TBL] [Abstract][Full Text] [Related]
15. Death-inducing tumour necrosis factor (TNF) superfamily ligands and receptors are transcribed in human placentae, cytotrophoblasts, placental macrophages and placental cell lines.
Phillips TA; Ni J; Hunt JS
Placenta; 2001; 22(8-9):663-72. PubMed ID: 11597186
[TBL] [Abstract][Full Text] [Related]
16. Proinflammatory effects of tumour necrosis factor-like weak inducer of apoptosis (TWEAK) on human gingival fibroblasts.
Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
Clin Exp Immunol; 2006 Dec; 146(3):540-9. PubMed ID: 17100776
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of a proliferation-inducing ligand (PRIL) suppresses the proliferation of gastric cancer cells.
Cui JW; Li Y; Wang C; Yao C; Li W
Asian Pac J Cancer Prev; 2012; 13(2):633-6. PubMed ID: 22524837
[TBL] [Abstract][Full Text] [Related]
18. The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-kappaB activation.
Brown SA; Richards CM; Hanscom HN; Feng SL; Winkles JA
Biochem J; 2003 Apr; 371(Pt 2):395-403. PubMed ID: 12529173
[TBL] [Abstract][Full Text] [Related]
19. Functional expression of TWEAK in human colonic adenocarcinoma cells.
Kawakita T; Shiraki K; Yamanaka Y; Yamaguchi Y; Saitou Y; Enokimura N; Yamamoto N; Okano H; Sugimoto K; Murata K; Nakano T
Int J Oncol; 2005 Jan; 26(1):87-93. PubMed ID: 15586228
[TBL] [Abstract][Full Text] [Related]
20. HMGB1 expression and secretion are increased via TWEAK-Fn14 interaction in atherosclerotic plaques and cultured monocytes.
Moreno JA; Sastre C; Madrigal-Matute J; Muñoz-García B; Ortega L; Burkly LC; Egido J; Martín-Ventura JL; Blanco-Colio LM
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):612-20. PubMed ID: 23288170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
